Add like
Add dislike
Add to saved papers

Ultrafiltration Rate Levels in Hemodialysis Patients Associated with Weight-Specific Mortality Risks.

BACKGROUND: We hypothesized that the association of ultrafiltration rate with mortality in hemodialysis patients was differentially affected by weight and sex, and sought to derive a sex and weight indexed ultrafiltration rate measure that captures the differential effects of these parameters on the association of ultrafiltration rate with mortality.

METHODS: Data were analyzed from the U.S. Fresenius Kidney Care (FKC) database for 1 year following patient entry into a FKC dialysis unit (baseline) and over 2 years of follow-up for patients receiving thrice weekly in-center hemodialysis. To investigate the joint effect of baseline-year ultrafiltration rate and postdialysis weight on survival, we fit Cox proportional hazards models using bivariate tensor product spline functions, and constructed contour plots of weight-specific mortality hazard ratios over the entire range of ultrafiltration rate values and postdialysis weights (W).

RESULTS: In the studied 396,358 patients, average ultrafiltration rate in ml/h was related to postdialysis weight (W) in kg: 3W+330. ultrafiltration rates associated with 20% or 40% increases in weight-specific mortality risk were 3W+500 and 3W+630 ml/h, respectively, and were 70 ml/h higher in men than in women. Eighteen and 8 percent of patients exceeded ultrafiltration rates associated with a 20% or 40% higher mortality risk. Low ultrafiltration rates were associated with subsequent weight loss. ultrafiltration rates associated with a given mortality risk were lower in high-body-weight elderly patients, and higher in patients on dialysis for more than 3 years.

CONCLUSIONS: Ultrafiltration rates (ultrafiltration rates) associated with various levels of higher mortality risk depend on body weight, but not in a 1:1 ratio, and are different in men vs. women, in high-body weight elderly, and in high-vintage patients.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app